2006
DOI: 10.1016/j.jneumeth.2005.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
29
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 55 publications
(33 citation statements)
references
References 9 publications
(12 reference statements)
4
29
0
Order By: Relevance
“…It is important to note that the molecular basis for this selectivity remains elusive. Furthermore, recent studies indicate that the selectivity of DSP4 for LC projections is relative, not absolute (Dailly et al, 2006). Our experience with DSP4 confirmed that withdrawal can be observed in WT mice when the LC output is abolished (Chieng and Christie, 1995;Caille et al, 1999) and in turn suggested a novel role for the central adrenergic system in opiate dependence (Fig.…”
Section: Discussionsupporting
confidence: 78%
“…It is important to note that the molecular basis for this selectivity remains elusive. Furthermore, recent studies indicate that the selectivity of DSP4 for LC projections is relative, not absolute (Dailly et al, 2006). Our experience with DSP4 confirmed that withdrawal can be observed in WT mice when the LC output is abolished (Chieng and Christie, 1995;Caille et al, 1999) and in turn suggested a novel role for the central adrenergic system in opiate dependence (Fig.…”
Section: Discussionsupporting
confidence: 78%
“…We also combined PCPA and ␣MT injections. PCPA treatments in mouse pups have been found previously to cause a 80 -50% decrease of brain 5-HT levels (Rebsam et al, 2005;Dailly et al, 2006). Anti-serotonin immunoreactivity showed a reduction of serotonin-immunolabeled axons after PCPA injections (Fig.…”
Section: Neurotransmitter Phenotypementioning
confidence: 64%
“…Our data failed to show an increase in cell death in the cerebral cortex. However, these pharmacological treatments are not specific and may cause only partial monoamine depletion [80% reduction of 5-HT in the cortex (Dailly et al, 2006); 50% in the whole brain (Rebsam et al, 2005)]. To avoid any confounding effect of pharmacological treatment, we used mice lacking the transcription factor Pet-1.…”
Section: Inhibition Of Monoamine Synthesismentioning
confidence: 99%
“…The reasons for these contradictory results are not clear, but there are several possible explanations. Whereas PCPA is very effective in depleting central 5-HT, it can also deplete peripheral 5-HT (Koe and Weissman, 1966) and other monoamines (Reader and Gauthier, 1984;Dailly et al, 2006), and does not affect neuropeptides colocalized in 5-HT neurons, such as thyrotropin-releasing hormone and substance P (Walker et al, 1990;Przegalinski et al, 1992). Possibly for these reasons, data obtained using PCPA have contributed previously to erroneous conclusions about the role of 5-HT in sleep (Jouvet, 1999).…”
Section: Role Of Central 5-ht Neurons In Respiratory Controlmentioning
confidence: 99%